Introduction
Hispanic/Latino men who have sex with men (MSM) and transgender women (TGW) are disproportionately
affected by HIV in the U.S. This study evaluated HIV prevention services and outcomes
among Hispanic/Latino MSM and TGW in the targeted highly effective interventions to
reduce the HIV epidemic (THRIVE) demonstration project and consider lessons learned.
Methods
The authors described the THRIVE demonstration project services provided to Hispanic/Latino
MSM and TGW in 7 U.S. jurisdictions from 2015 to 2020. HIV prevention service outcomes
were compared between 1 site with (2,147 total participants) and 6 sites without (1,129
total participants) Hispanic/Latino-oriented pre-exposure prophylaxis clinical services,
and Poisson regression was used to estimate the adjusted RR between sites and pre-exposure
prophylaxis outcomes. Analyses were conducted from 2021 to 2022.
Results
The THRIVE demonstration project served 2,898 and 378 Hispanic/Latino MSM and TGW,
respectively, with 2,519 MSM (87%) and 320 TGW (85%) receiving ≥1 HIV screening test.
Among 2,002 MSM and 178 TGW eligible for pre-exposure prophylaxis, 1,011 (50%) MSM
and 98 (55%) TGW received pre-exposure prophylaxis prescriptions, respectively. MSM
and TGW were each 2.0 times more likely to be linked to pre-exposure prophylaxis (95%
CI=1.4, 2.9 and 95% CI=1.2, 3.6, respectively) and 1.6 and 2.1 times more likely to
be prescribed pre-exposure prophylaxis (95% CI=1.1, 2.2 and 95% CI=1.1, 4.1), respectively,
at the site providing Hispanic/Latino-oriented pre-exposure prophylaxis clinical services
than at other sites and adjusted for age group.
Conclusions
The THRIVE demonstration project delivered comprehensive HIV prevention services to
Hispanic/Latino MSM and TGW. Hispanic/Latino-oriented clinical settings may improve
HIV prevention service delivery to persons in Hispanic/Latino communities.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Preventive MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Estimated HIV incidence and prevalence in the United States, 2015–2019.Centers for Disease Control and Prevention, Atlanta, GA2021 (Published May 2021. Accessed February 17, 2023)
- Estimating the prevalence of HIV and sexual behaviors among the U.S. transgender population: a systematic review and meta-analysis, 2006–2017.Am J Public Health. 2019; 109: e1-e8https://doi.org/10.2105/AJPH.2018.304727
- HIV infection, risk, prevention, and testing behaviors among transgender women—national HIV behavioral surveillance, 7 U.S. Cities, 2019–2020.Centers for Disease Control and Prevention, Atlanta, GA2021 (Published April 2021. Accessed February 17, 2023)
- Toward greater pre-exposure prophylaxis equity: increasing provision and uptake for Black and Hispanic/Latino individuals in the U.S.Am J Prev Med. 2021; 61 (5): S60-S72https://doi.org/10.1016/j.amepre.2021.05.027
- Ending the HIV Epidemic: a plan for the United States.JAMA. 2019; 321: 844-845https://doi.org/10.1001/jama.2019.1343
- Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men - 23 urban areas, 2017.MMWR Morb Mortal Wkly Rep. 2019; 68: 801-806https://doi.org/10.15585/mmwr.mm6837a2
Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): national HIV Surveillance System data reported through March 2022; and preexposure prophylaxis (PrEP) data reported through December 2021. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-3-no-2/index.html. Updated August 9, 2022. Accessed December 20, 2022.
- A critical review and commentary on the challenges in engaging HIV-infected Latinos in the continuum of HIV care.AIDS Behav. 2018; 22: 2500-2512https://doi.org/10.1007/s10461-018-2187-1
- Barriers to HIV testing within a sample of Spanish-speaking Latinx gay, bisexual, and other men who have sex with men: implications for HIV prevention and care.Health Behav Res. 2019; 2 (10.4148/2572-1836.1069)https://doi.org/10.4148/2572-1836.1069
- Multilevel barriers to HIV PrEP uptake and adherence among Black and Hispanic/Latinx transgender women in Southern California.AIDS Behav. 2021; 25: 2301-2315https://doi.org/10.1007/s10461-021-03159-2
- The invisible U.S. Hispanic/Latino HIV crisis: addressing gaps in the national response.Am J Public Health. 2020; 110: 27-31https://doi.org/10.2105/AJPH.2019.305309
- Association of HIV pre-exposure prophylaxis awareness, preferred Spanish (vs. English) language use, and sociodemographic variables among Hispanic/Latino men who have sex with men.Ann Epidemiol. 2019; 31: 8-10https://doi.org/10.1016/j.annepidem.2019.01.003
- PrEP awareness and decision-making for Latino MSM in San Antonio, Texas.PLoS One. 2017; 12e0184014https://doi.org/10.1371/journal.pone.0184014
- Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review.Adv Ther. 2020; 37: 1778-1811https://doi.org/10.1007/s12325-020-01295-0
- A promising PrEP navigation intervention for transgender women and men who have sex with men experiencing multiple syndemic health disparities.J Community Health. 2019; 44: 1193-1203https://doi.org/10.1007/s10900-019-00705-x
- Oral abstracts of the 10th IAS Conference on HIV Science, 21-24 July 2019, Mexico City, Mexico.J Int AIDS Soc. 2019; 22: e25327https://doi.org/10.1002/jia2.25327
- Empowering with PrEP (E-PrEP), a peer-led social media-based intervention to facilitate HIV preexposure prophylaxis adoption among young Black and Latinx gay and bisexual men: protocol for a cluster randomized controlled trial.JMIR Res Protoc. 2018; 7: e11375https://doi.org/10.2196/11375
- A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection.AIDS Behav. 2021; 25: 1411-1422https://doi.org/10.1007/s10461-020-02979-y
About THRIVE. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/research/thrive/about.html. Updated August 15, 2022. Accessed December 20, 2022.
- Key factors for successful implementation of HIV prevention services by THRIVE community collaboratives.Public Health Rep. 2022; 137: 310-316https://doi.org/10.1177/00333549211005793
- Decreased human immunodeficiency virus diagnosis rates among black and hispanic or latino men who have sex with men in U.S. jurisdictions supported by the THRIVE demonstration project, 2014-2019.Clin Infect Dis. 2023; 76: 307-314https://doi.org/10.1093/cid/ciac774
Kimball AA, Zhu W, Tanner MR, et al. The effect of navigation on linkage to a PrEP provider among PrEP-eligible men who have sex with men in a U.S. Demonstration project. AIDS Behav. In press. Online November 22, 2022. https://doi.org/10.1007/s10461-022-03931-y.
- HIV pre-exposure prophylaxis services for Black and Hispanic or Latino gay, bisexual, and other men who have sex with men and transgender women in THRIVE, 2015–2020.J Acquir Immune Defic Syndr. 2022; (In press. Online December 8)https://doi.org/10.1097/QAI.0000000000003138
- Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline.Centers for Disease Control and Prevention, Atlanta, GA2018 (Published March 2018. Accessed February 17, 2023)
America's HIV epidemic analysis dashboard (AHEAD). HHS. https://ahead.hiv.gov/. Updated 2021. Accessed December 20, 2022.
- Impact of a bilingual/bicultural care team on HIV-related health outcomes.J Assoc Nurses AIDS Care. 2008; 19: 295-301https://doi.org/10.1016/j.jana.2008.04.004
- Reducing cultural and psychological barriers to Latino enrollment in HIV-prevention counseling: initial data on an enrollment meta-intervention.AIDS Care. 2013; 25: 881-887https://doi.org/10.1080/09540121.2012.729803
- A peer navigation intervention to prevent HIV among mixed immigrant status Latinx GBMSM and transgender women in the United States: outcomes, perspectives and implications for PrEP uptake.Health Educ Res. 2020; 35: 165-178https://doi.org/10.1093/her/cyaa010
- Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health.Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD2020 (Published 2020. Accessed December 20, 2022)
- Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system.NAM Perspect. 2020; 2020 (10.31478/202004b)https://doi.org/10.31478/202004b
National Academies of Sciences, Engineering, Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Medication-Assisted Treatment for Opioid Use Disorder, M Mancher and AI Leshner, Medications for Opioid Use Disorder Save Lives, 2019, The National Academies Press; Washington, DC.https://nap.nationalacademies.org/catalog/25310/medications-for-opioid-use-disorder-save-lives. Accessed February 17, 2023..
- How physician workforce shortages are hampering the response to the opioid crisis.Psychiatr Serv. 2022; 73: 547-554https://doi.org/10.1176/appi.ps.202000565
- Substance use and misuse among sexual and gender minority youth.Curr Opin Psychol. 2019; 30: 123-127https://doi.org/10.1016/j.copsyc.2019.05.002
- The availability of sexual and gender minority (SGM) specific substance use services.Subst Use Misuse. 2022; 57: 2126-2133https://doi.org/10.1080/10826084.2022.2137812
- 2015 U.S. Transgender Survey: Report on the Experiences of Latino/a Respondents.National Center for Transgender Equality and [email protected], Washington, DC and Los Angeles, CA2017 (Published 2017. Accessed December 20, 2022)
- HIV prevention among transgender populations: knowledge gaps and evidence for action.Curr HIV/AIDS Rep. 2017; 14: 141-152https://doi.org/10.1007/s11904-017-0360-1
- Comprehensive HIV prevention for transgender persons.Am J Public Health. 2017; 107: 207-212https://doi.org/10.2105/AJPH.2016.303509
- HIV infection risk factors among male-to-female transgender persons: a review of the literature.J Assoc Nurses AIDS Care. 2009; 20: 362-372https://doi.org/10.1016/j.jana.2009.06.005
Article info
Publication history
Published online: March 03, 2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.
